Leerink Swann Analysts Decrease Earnings Estimates for Amgen, Inc.

Leerink Swann Analysts Decrease Earnings Estimates for Amgen, Inc.


Research analysts at Leerink Swann decreased their Q4 2017 earnings estimates for shares of Amgen in a research note issued on Thursday. Leerink Swann analyst G. Porges now forecasts that the medical research company will post earnings per share of $2.90 for the quarter, down from their prior forecast of $2.93.



from Biotech News